BrightSpec Announces $18.4 Million Financing Round

BrightSpec, Inc., a life science tools company commercializing Molecular Rotational Resonance (MRR) spectroscopy, announced today the closing of an $18.4 million Series C financing round, led by Genoa Ventures and Arboretum Ventures.

Read the rest of the story on Cision PR Newswire